Related Experiment Video

Updated: Sep 28, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Behavioral intervention for meth-using MSM. Researchers want to spread word

    AIDS Alert
    |November 5, 2002
    PubMed

    Insights

    New research highlights methamphetamine abuse as a risk factor for HIV transmission among men who have sex with men (MSM). A specialized treatment program in Los Angeles specifically targets this vulnerable population.

    Area of Science:

    • Public Health
    • Addiction Medicine
    • HIV Research

    Background:

    • Substance abuse treatment programs often lack focus on methamphetamine (meth) abuse.
    • Methamphetamine use is increasingly linked to HIV transmission, particularly among men who have sex with men (MSM).
    • Existing interventions are not tailored to the specific needs of MSM who abuse meth.

    Discussion:

    • This study introduces a novel treatment program designed for MSM with methamphetamine use disorder.
    • The program aims to address the intersection of substance abuse and HIV risk in a specific demographic.
    • Tailored interventions are crucial for addressing complex health issues in vulnerable populations.

    Key Insights:

    • A new, targeted intervention program has been developed for MSM who abuse methamphetamine.
    • This program addresses a critical gap in substance abuse treatment for a high-risk group.
    • Early research suggests the potential for specialized programs to mitigate HIV transmission risks associated with meth use.

    Outlook:

    • Further research is needed to evaluate the efficacy and scalability of this targeted intervention.
    • This model may inform the development of similar programs for other at-risk populations.
    • Continued focus on integrated care for substance abuse and infectious diseases is essential.

    More Related Videos

    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods09:29

    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

    Published on: August 4, 2022

    Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats09:43

    Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

    Published on: October 5, 2021

    Related Concept Videos

    Phase II Reactions: Methylation Reactions01:17

    Phase II Reactions: Methylation Reactions

    Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
    The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
    Therapeutic Drug Monitoring: Affecting Factors01:29

    Therapeutic Drug Monitoring: Affecting Factors

    Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.